Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban vs enoxaparin for prophylaxis of venous thromboembolism after knee or hip arthroplasty
IRCT20161121031003N4Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban and enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by Iran University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
rivaroxabanenoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on IRCT20161121031003N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161121031003N4.